In pursuit of its rapid growth and expansion plans, Caris Diagnostics (Irving, TX) has announced plans to acquire Molecular Profiling Institute Inc. (MPI; Phoenix), a CLIA-certified molecular diagnostics company and reference laboratory focused on developing and commercializing novel molecular diagnostic tests based on genomic and proteomic profiling. Financial terms of the acquisition agreement were not disclosed.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 2008 - Table of Contents

LIR January 2008 (full PDF issue)

Competitive Demo Bids Due Feb. 15: CMS Confirms List of Excluded Cities

Quest, LabCorp, Sonic Land Humana Contract Extensions

‘First to File’ Patent Reform Efforts Underscore Labs’ Need to Protect IP

Goldman Sachs Identifies Current Challenges, Future Growth for Quest and LabCorp

Outlook for the Lab Industry: Five Execs’ Predictions for 2008

India’s Lal PathLabs Intent on Outsourcing United States Testing

Lab Stocks up 17% in ’07, Two New Companies Added for 2008

Caris Diagnostics to Acquire Molecular Profiling Institute